Accelerate drug time to market through real study traceability and unparalleled trial integrity
Verisian has raised $4.3M in total funding. The most recent round was Seed. The last funding was announced in May 2025.
Verisian's investors include Dimension Capital, Seedcamp, SuperSeed Ventures, Recode Health Ventures, Will Neale.
Verisian is headquartered in London, United Kingdom.
Accelerate drug time to market through real study traceability and unparalleled trial integrity
Verisian is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Verisian — Funding & Investors." VCBacked, May 29, 2025, https://www.vcbacked.co/company/verisian. Accessed July 19, 2026.
VCBacked. (2025). Verisian — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/verisian
{{cite web |title=Verisian — Funding & Investors |url=https://www.vcbacked.co/company/verisian |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated